Teodoro Bottiglieri, PhD
- 6Articles
- 32.5KReads1
- 2004–2017Active
- 23Collaborators
- 259Citations2
About
Teodoro Bottiglieri, PhD, has published extensively on the neuropsychiatric applications of S-Adenosylmethionine (SAMe), with a focus on its bioavailability and clinical effects in major depressive disorder (MDD). The research also addresses the role of serum folate, vitamin B12, and homocysteine as predictors of treatment response and relapse in depression, as well as adjunctive therapies for SSRI-resistant patients. Bottiglieri's work spans from 2004 to 2017 and includes studies related to depression and Alzheimer disease. Collaborations frequently include David Mischoulon, George I. Papakostas, Maurizio Fava, Jonathan E. Alpert, and Andrew A. Nierenberg.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
